These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38225941)

  • 1. Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant
    Bonsa Z; Tadesse M; Balay G; Kebede W; Abebe G
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100410. PubMed ID: 38225941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    Tilahun M; Wegayehu T; Wondale B; Gebresilase TT; Gebreyohannes T; Tekola A; Alemu M; Neway S; Adnew B; Nassir MF; Kassahun Y; Aseffa A; Bobosha K
    PLoS One; 2023; 18(9):e0285063. PubMed ID: 37682820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of discrepant results between genotypic MTBDR
    Kang JY; Hur J; Kim S; Jeon S; Lee J; Kim YJ; Kim SC; Park YJ; Kim YK; Moon HS
    J Thorac Dis; 2019 Feb; 11(2):400-409. PubMed ID: 30962983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin-resistant TB: discordance between Xpert
    Black M; Da Silva P; Scott L
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):832-838. PubMed ID: 34615580
    [No Abstract]   [Full Text] [Related]  

  • 5. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant
    Bokop C; Faye LM; Apalata T
    Pathogens; 2023 Jul; 12(7):. PubMed ID: 37513756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
    Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
    Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube.
    Gurbanova E; Mehdiyev R; Blondal K; Tahirli R; Mirzayev F; Hillemann D; Ismayilov A; Altraja A
    Microb Drug Resist; 2017 Dec; 23(8):1045-1052. PubMed ID: 28447869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.
    Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W
    Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
    PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.
    Kurbatova EV; Kaminski DA; Erokhin VV; Volchenkov GV; Andreevskaya SN; Chernousova LN; Demikhova OV; Ershova JV; Kaunetis NV; Kuznetsova TA; Larionova EE; Smirnova TG; Somova TR; Vasilieva IA; Vorobieva AV; Zolkina SS; Cegielski JP
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):735-43. PubMed ID: 23263819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods.
    Mwanza W; Milimo D; Chilufya MM; Kasese N; Lengwe MC; Munkondya S; de Haas P; Ayles H; Muyoyeta M
    Afr J Lab Med; 2018; 7(2):806. PubMed ID: 30568904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].
    Nosova EIu; Krasnova MA; Galkina KIu; Makarova MV; Litvinov VI; Moroz AM
    Mol Biol (Mosk); 2013; 47(2):267-74. PubMed ID: 23808160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant
    He G; Zheng Q; Wu J; Wu L; Geng Z; Jiang G; Huang H; Jiang X; Yu X
    Microbiol Spectr; 2024 Jun; 12(6):e0385923. PubMed ID: 38738892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.
    Ardizzoni E; Ariza E; Mulengwa D; Mpala Q; de La Tour R; Maphalala G; Varaine F; Kerschberger B; Graulus P; Page AL; Niemann S; Dreyer V; Van Deun A; Decroo T; Rigouts L; de Jong BC
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis.
    Yadav RN; Kumar Singh B; Sharma R; Chaubey J; Sinha S; Jorwal P
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):237-244. PubMed ID: 33657709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.
    Cayci YT; Bilgin K; Coban AY; Birinci A; Durupınar B
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):756-759. PubMed ID: 29091135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.